Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
S 0.105 −32.3% OMI 0.310 −1.6% BMM 4.02 +5.8% CGD 0.630 +10.5% OCG 0.265 −5.4% CAMB 0.950 −5.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 1.00 −2.9% SGQ 0.400 +33.3% AMCO 0.225 −10.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.395 −1.2% LIB 0.790 −13.2% SMY 0.290 +23.4% S 0.105 −32.3% OMI 0.310 −1.6% BMM 4.02 +5.8% CGD 0.630 +10.5% OCG 0.265 −5.4% CAMB 0.950 −5.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 1.00 −2.9% SGQ 0.400 +33.3% AMCO 0.225 −10.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.395 −1.2% LIB 0.790 −13.2% SMY 0.290 +23.4%

Cannabis

Page 50
  1. Nov 17, 2025 · 16:45 · LOVE

    Cannara Biotech to release fiscal 2025 results Nov. 24

    Cannara Biotech to release fiscal 2025 results Nov. 24

    01
  2. Nov 17, 2025 · 16:38 · HERB

    Herbal Dispatch has sales of $4.1-million in October

    Herbal Dispatch has sales of $4.1-million in October

    02
  3. Nov 17, 2025 · 07:30 · LEEF

    LEEF Brands Announces Insider Share Purchases Following Strong Q3 Results

    LEEF Brands Announces Insider Share Purchases Following Strong Q3 Results

    03
  4. Nov 17, 2025 · 07:30 · AYR

    AYR Wellness to Initiate CCAA Proceedings

    AYR Wellness to Initiate CCAA Proceedings

    04
  5. Nov 17, 2025 · 07:02 · HERB

    Herbal Dispatch Announces Record-Breaking Month of $4.1M in Sales for October 2025

    Herbal Dispatch Announces Record-Breaking Month of $4.1M in Sales for October 2025

    05
  6. Nov 17, 2025 · 07:00 · LOVE

    Cannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board Update

    Cannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board Update

    06
  7. Nov 14, 2025 · 18:29 · AVCN

    Avicanna talks adj. EBITDA in Q3 2025 results

    Avicanna talks adj. EBITDA in Q3 2025 results

    07
  8. Nov 14, 2025 · 17:30 · AVCN

    Avicanna Reports Q3 2025

    Avicanna Reports Q3 2025

    08
  9. Nov 14, 2025 · 16:46 · LABS

    Medipharm wins full anti-SLAPP defamation dismissal

    Medipharm wins full anti-SLAPP defamation dismissal

    09
  10. Nov 13, 2025 · 13:41 · MOOD

    Doseology Sciences unit signs manufacturing deal

    Doseology Sciences unit signs manufacturing deal

    10
  11. Nov 13, 2025 · 08:00 · LABS

    MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains

    MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains

    11
  12. Nov 13, 2025 · 07:45 · XLY

    Auxly Reports Third Quarter 2025 Results

    Auxly Reports Third Quarter 2025 Results

    12
  13. Nov 13, 2025 · 04:00 · MOOD

    Doseology Completes Extensive North American Diligence, Securing Strategic Manufacturing Agreement via U.S. Subsidiary Doseology USA Inc.

    Doseology Completes Extensive North American Diligence, Securing Strategic Manufacturing Agreement via U.S. Subsidiary Doseology USA Inc.

    13
  14. Nov 12, 2025 · 21:47 · ROMJ

    Rubicon Organics Reports Q3 2025 Financial and Operating Results

    Rubicon Organics Reports Q3 2025 Financial and Operating Results

    14
← Newer Older →